Evolution of cerebrospinal fluid total α-synuclein in Parkinson's disease-Reference-Cited by-同舟云学术

Evolution of cerebrospinal fluid total α-synuclein in Parkinson's disease

Published:2018-04 Issue: Volume:49 Page:4-8
ISSN:1353-8020
Container-title:Parkinsonism & Related Disorders
language:en
Short-container-title:Parkinsonism & Related Disorders

Author:

Førland Marthe Gurine,Öhrfelt Annika,Dalen Ingvild,Tysnes Ole-Bjørn,Blennow Kaj,Zetterberg Henrik,Pedersen Kenn Freddy,Alves Guido,Lange Johannes^ORCID

Funder

Western Norway Regional Health Authority

Norwegian Parkinson's Disease Association

Swedish Research Council

European Research Council

Knut and Alice Wallenberg Foundation

Torsten Söderberg Foundation

Swedish Brain Foundation

Swedish Alzheimer Foundation

Publisher

Elsevier BV

Subject

Neurology (clinical),Geriatrics and Gerontology,Neurology

Reference30 articles.

1. Alpha-Synuclein and protein degradation systems: a reciprocal relationship;Xilouri;Mol. Neurobiol.,2013

2. Value of cerebrospinal fluid alpha-synuclein species as biomarker in Parkinson's diagnosis and prognosis;Parnetti;Biomarkers Med.,2016

3. D.I. Parkinson Study Group, cerebrospinal fluid alpha-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort;Stewart;Am. J. Pathol.,2014

4. Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression;Majbour;Mov. Disord.,2016

5. Longitudinal measurements of cerebrospinal fluid biomarkers in Parkinson's disease;Hall;Mov. Disord.,2016

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling Parkinson’s disease through biomarker research: current insights and future prospects;Critical Reviews in Clinical Laboratory Sciences;2024-03-26

2. Voxel-based morphometry reveals the correlation between gray matter volume and serum P-tau-181 in type 2 diabetes mellitus patients with different HbA1c levels;Frontiers in Neuroscience;2023-05-15

3. CSF neurochemical profile and cognitive changes in Parkinson’s disease with mild cognitive impairment;npj Parkinson's Disease;2023-04-24

4. Cerebrospinal fluid alpha-synuclein, amyloid beta, total tau, and phosphorylated tau in tremor-dominant Parkinson’s disease;Acta Neurologica Belgica;2023-03-31

5. α-synuclein as a promising biomarker for developing diagnostic tools against neurodegenerative synucleionopathy disorders;TrAC Trends in Analytical Chemistry;2023-02